Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Feb 3;16(3):484-94.
doi: 10.1093/emboj/16.3.484.

The mammalian profilin isoforms display complementary affinities for PIP2 and proline-rich sequences

Affiliations

The mammalian profilin isoforms display complementary affinities for PIP2 and proline-rich sequences

A Lambrechts et al. EMBO J. .

Abstract

We present a study on the binding properties of the bovine profilin isoforms to both phosphatidylinositol 4,5-bisphosphate (PIP2) and proline-rich peptides derived from vasodilator-stimulated phosphoprotein (VASP) and cyclase-associated protein (CAP). Using microfiltration, we show that compared with profilin II, profilin I has a higher affinity for PIP2. On the other hand, fluorescence spectroscopy reveals that proline-rich peptides bind better to profilin II. At micromolar concentrations, profilin II dimerizes upon binding to proline-rich peptides. Circular dichroism measurements of profilin II reveal a significant conformational change in this protein upon binding of the peptide. We show further that PIP2 effectively competes for binding of profilin I to poly-L-proline, since this isoform, but not profilin II, can be eluted from a poly-L-proline column with PIP2. Using affinity chromatography on either profilin isoform, we identified profilin II as the preferred ligand for VASP in bovine brain extracts. The complementary affinities of the profilin isoforms for PIP2 and the proline-rich peptides offer the cell an opportunity to direct actin assembly at different subcellular localizations through the same or different signal transduction pathways.

PubMed Disclaimer

References

    1. J Biol Chem. 1995 Sep 8;270(36):21114-20 - PubMed
    1. Protein Sci. 1995 Mar;4(3):450-9 - PubMed
    1. Cell Motil Cytoskeleton. 1989;14(2):251-62 - PubMed
    1. J Mol Biol. 1977 Sep 25;115(3):465-83 - PubMed
    1. Eur J Biochem. 1985 Sep 2;151(2):291-7 - PubMed

Publication types

MeSH terms